β-Ionone and its analogs as promising anticancer agents

European Journal of Medicinal Chemistry

Volumn 123, Issue , 2016, Pages 141-154

  Ansari, Mahsa ^a   Emami, Saeed ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti proliferative activity; Anticancer agents; Apoptosis; Drug design; Terpenoid derivatives; Ionone

Indexed keywords

3 HYDROXYIONOL; 3 OXO IONOL; 3 OXO IONONE; ALPHA CAROTENE; ALPHA IONONE; ANTINEOPLASTIC AGENT; BETA CAROTENE; BETA IONONE; BETA LACTAM DERIVATIVE; CHALCONE DERIVATIVE; CORN OIL; COUMARIN DERIVATIVE; CURCUMIN; DIHYDRO 3 OXO IONOL; DIMETHYLBENZ[A]ANTHRACENE; GAMMA BUTYROLACTONE DERIVATIVE; GERANIOL; GERANYLGERANIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IONONE DERIVATIVE; ISOXAZOLE DERIVATIVE; OXADIAZOLE DERIVATIVE; PSEUDOIONONE; QUINAZOLINE DERIVATIVE; SORAFENIB; TERPENOID DERIVATIVE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; BETA-IONONE; NORISOPRENOID;

ADDITION REACTION; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BIOCHEMISTRY; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CELL VIABILITY; CHEMOPROPHYLAXIS; CYCLIZATION; CYTOTOXICITY; DRUG MECHANISM; EPOXIDATION; HUMAN; IC50; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LIVER CANCER; MEDICINAL CHEMISTRY; NEOPLASM; NONHUMAN; OSTEOSARCOMA; OXIDATION; PHOTOCHEMISTRY; POLYMERIZATION; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; NEOPLASM METASTASIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; NEOPLASM METASTASIS; NORISOPRENOIDS; SIGNAL TRANSDUCTION;

EID: 84979585469     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2016.07.037     Document Type: Review

References (102)

1. [1] Nacke, C., Hüttmann, S., Etschmann, M.M., Schrader, J., Enzymatic production and in situ separation of natural β-ionone from β-carotene. J. Ind. Microbiol. Biotechnol. 39 (2012), 1771–1778.
2. [2] Gomes-Carneiro, M.R., de-Oliveira, A.C.A.X., de-Carvalho, R.R., Araujo, I.B., Souza, C.A.M., Kuriyama, S.N., Paumgartten, F.J.R., Inhibition of cyclophosphamide-induced teratogenesis by β-ionone. Toxicol. Lett. 138 (2003), 205–213.
3. [3] Gomes-Carneiro, M.R., Daniela Dias, M.M., Francisco J.R. Paumgartten, Study on the mutagenicity and antimutagenicity of β-ionone in the almonella/microsome assay. Food Chem. Toxicol. 44 (2006), 522–527.
4. [4] Jones, G.J., Korth, W., In situ production of volatile odour compounds by river and reservoir phytoplankton populations in Australia. Water Sci. Technol. 31 (1995), 145–151.
5. [5] Belsito, D., Bickers, D., Bruze, M., Calow, P., Greim, H., Hanifin, J.M., Rogers, A.E., Saurat, J.H., Sipes, I.G., Tagami, H., A toxicologic and dermatologic assessment of ionones when used as fragrance ingredients. Food Chem. Toxicol. 45 (2007), S130–S167.
6. [6] Suryawanshi, S.N., Bhat, B.A., Pandey, S., Chandra, N., Gupta, S., Chemotherapy of leishmaniasis. Part VII: synthesis and bioevaluation of substituted terpenyl pyrimidines. Eur. J. Med. Chem. 42 (2007), 1211–1217.
7. [7] Balbi, A., Anzaldi, M., Mazzei, M., Miele, M., Bertolotto, M., Ottonello, L., Dallegri, F., Synthesis and biological evaluation of novel heterocyclic ionone-like derivatives as anti-inflammatory agents. Bioorg. Med. Chem. 14 (2006), 5152–5160.
8. [8] Sharma, V., Singh, G., Kaur, H., Saxena, A.K., Ishar, M.P.S., Synthesis of β-ionone derived chalcones as potent antimicrobial agents. Bioorg. Med. Chem. Lett. 22 (2012), 6343–6346.
9. [9] Markovich, Y.D., Panfilov, A.V., Platunov, Y.N., Zhirov, A.A., Kosenko, S.I., Kirsanov, A.T., New cyclization agents for the synthesis of beta-ionone from pseudoionone. Pharm. Chem. J. 32 (1998), 603–605.
10. [10] Duncan, R.E., Lau, D., El-Sohemy, A., Archer, M.C., Geraniol and β-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem. Pharmacol. 68 (2004), 1739–1747.
11. [11] Liu, J.R., Chen, B.Q., Yang, B.F., Dong, H.W., Sun, C.H., Wang, Q., Song, G., Song, Y.Q., Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World J. Gastroenterol. 10 (2004), 348–351.
12. [12] Janakiram, N.B., Cooma, I., Mohammed, A., Steele, V.E., Rao, C.V., β-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-α in human colon cancer cells. Mol. Cancer Ther. 7 (2008), 181–190.
13. [13] Faezizadeh, Z., Gharib, A., Goudarzi, M., The effect of β-ionone on telomerase activity in the human leukemia cell line K562. J. Kermanshah Univ. Med. Sci. 19 (2015), 118–127.
14. [14] Wang, H., Khor, T.O., Shu, L., Su, Z., Fuentes, F., Lee, J.H., et al. Plants against cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med. Chem. 12 (2012), 1281–1305.
15. [15] Holohan, C., Van Schaeybroeck, S., Longley, D.B., Johnston, P.G., Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13 (2013), 714–726.
16. [16] Baldermann, S., Kato, M., Kurosawa, M., Kurobayashi, Y., Fujita, A., Fleischmann, P., Watanabe, N., Functional characterization of a carotenoid cleavage dioxygenase 1 and its relation to the carotenoid accumulation and volatile emission during the floral development of Osmanthus fragrans Lour. J. Exp. Bot. 61 (2010), 2967–2977.
17. [17] SIDS Initial Assessment Report for SIAM 20 Paris, France, 19–22 April 2004.
18. [18] Bosser, A., Belin, J.M., Synthesis of β-Ionone in an aldehyde/xanthine oxidase/β-carotene system involving free radical formation. Biotechnol. Prog. 10 (1994), 129–133.
19. [19] Ide, H., Toki, S., Metabolism of β-ionone. Isolation, characterization and identification of the metabolites in the urine of rabbits. Biochem. J. 119 (1970), 281–287.
20. [20] Markovich, Y.D., Panfilov, A.V., Zhirov, A.A., Kirsanov, A.T., Gorbach, L.A., Taraskin, K.A., Beta-ionone synthesis using anhydrous hydrogen fluoride. Pharm. Chem. J. 32 (1998), 557–559.
21. [21] Royals, E.E., Cyclization of pseudoionone by acidic reagents. Ind. Eng. Chem. 38 (1946), 546–548.
22. [22] Kashid, M.N., Yuranov, I., Raspail, P., Prechtl, P., Membrez, J., Renken, A., Kiwi-Minsker, L., Cyclization of pseudoionone to β-ionone: reaction mechanism and kinetics. Ind. Eng. Chem. Res. 50 (2011), 7920–7926.
23. [23] Zhou, J., Geng, G., Shi, Q., Sauriol, F., Wu, J.H., Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance. J. Med. Chem. 52 (2009), 5546–5550.
24. [24] Pori, M., Galletti, P., Soldati, R., Calzà, L., Mangano, C., Giacomini, D., Azetidinone-retinoid hybrids: synthesis and differentiative effects. Eur. J. Med. Chem. 70 (2013), 857–863.
25. [25] Wertz, P.W., Kensler, T.W., Mueller, G.C., Inhibition of phorbol ester action in lymphocytes by 5,6-epoxy-beta-ionone. Biochem. Biophys. Res. Commun. 83 (1978), 138–143.
26. [26] Liu, C., Li, F., Tang, R., Effective aerobic allylic oxidation of β-ionone and series of olefins catalyzed by phosphomolybdic acid. Bull. Korean Chem. Soc. 31 (2010), 1723–1725.
27. [27] Kamat, S.P., D'Souza, A.M., Paknikar, S.K., Bhadbhade, M.M., Gonnade, R.G., Unusual KMnO4oxidation product of β-ionone. Indian J. Chem. 46B (2007), 1038–1041.
28. [28] Naves, Y.R., Some developments in the chemistry of ionones and their derivatives– a subject review. J. Soc. Cosmet. Chem. 22 (1971), 439–456.
29. [29] Singletary, K., Diet, natural products and cancer chemoprevention. J. Nutr. 130 (2000), 465S–466S.
30. [30] Mo, H., Elson, C.E., Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp. Biol. Med. (Maywood) 229 (2004), 567–585.
31. [31] Liu, J.R., Yang, B.F., Chen, B.Q., Yang, Y.M., Dong, H.W., Song, Y.Q., Inhibition of β-ionone on SGC-7901 cell proliferation and up regulation of metalloproteinases-1 and -2 expressions. World J. Gastroenterol. 10 (2004), 167–171.
32. [32] Lin, J.R., Chen, B.Q., Yang, Y.M., Sun, X.R., Dong, H., Wang, Q., Yang, B., Inhibitory effect of potential metastasis in SGC-7901 cells induced by beta-ionone. Article in Chinese Wei Sheng Yan Jiu 34 (2005), 435–438.
33. [33] Sun, X., Liu, J., Sun, W., Tang, X., Beta-ionone induced apoptosis in SGC-7901 cells. Article in Chinese Wei Sheng Yan Jiu 36 (2007), 667–670.
34. [34] Liu, Q., Dong, H.W., Sun, W.G., Liu, M., Ibla, J.C., Liu, L.X., Parry, J.W., Han, X.H., Li, M.S., Liu, J.R., Apoptosis initiation of β-ionone in SGC-7901 gastric carcinoma cancer cells via a PI3K-AKT pathway. Arch. Toxicol. 87 (2013), 481–490.
35. [35] Dong, H.W., Zhang, S., Sun, W.G., Liu, Q., Ibla, J.C., Soriano, S.G., Han, X.H., Liu, L.X., Li, M.S., Liu, J.R., β-Ionone arrests cell cycle of gastric carcinoma cancer cells by a MAPK pathway. Arch. Toxicol. 87 (2013), 1797–1808.
36. [36] Liu, J., Li, B., Ma, R., Chen, B., Inhibitory effect on mammary carcinoma cells induced by β-ionone. Article in Chinese Wei Sheng Yan Jiu 33 (2004), 151–153.
37. [37] Liu, J.R., Yang, Y.M., Dong, H.W., Sun, X.R., Effect of beta-ionone in human mammary cancer cells (Er-) by MAPK pathway. Article in Chinese Wei Sheng Yan Jiu 34 (2005), 706–709.
38. [38] Jones, S., Fernandes, N.V., Yeganehjoo, H., Katuru, R., Qu, H., Yu, Z., Mo, H., β-Ionone induces cell cycle arrest and apoptosis in human prostate tumor cells. Nutr. Cancer 65 (2013), 600–610.
39. [39] Huang, C.S., Lyu, S.C., Chen, J.Y., Hu, M.L., The anti-metastatic efficacy of β-ionone and the possible mechanisms of action in human hepatocarcinoma SK-Hep-1 cells. Br. J. Nutr. 107 (2012), 631–638.
40. [40] Huang, C.S., Lyu, S.C., Hu, M.L., Synergistic effects of the combination of β-ionone and sorafenib on metastasis of human hepatoma SK-Hep-1 cells. Investig. New Drugs 30 (2012), 1449–1459.
41. [41] Zhu, J., Zhang, L., Jin, X., Han, X., Sun, C., Yan, J., β-Ionone-induced apoptosis in human osteosarcoma (U2os) cells occurs via a p53-dependent signaling pathway. Mol. Biol. Rep. 37 (2010), 2653–2663.
42. [42] Cardozo, M.T., de Conti, A., Ong, T.P., Scolastici, C., Purgatto, E., Horst, M.A., Bassoli, B.K., Moreno, F.S., Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J. Nutr. Biochem. 22 (2011), 130–135.
43. [43] Cardozo, M.T., Furtado, K.S., De Conti, A., de Oliveira Andrade, F., Fernandes, L.H., Campos, A., Scolastici, C., Moreno, F.S., The chemopreventive activity of β-ionone involves modulation of Rxrα, Rarβ and Coup-Tf1 expression in liver pre-neoplastic lesions in rats. Curr. Drug Targets, 2015.
44. [44] Liu, J.R., Sun, X.R., Dong, H.W., Sun, C.H., Sun, W.G., Chen, B.Q., Song, Y.Q., Yang, B.F., beta-Ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat. Int. J. Cancer 122 (2008), 2689–2698.
45. [45] Liu, J.R., Dong, H.W., Sun, X.R., Wang, Q., Sun, W.G., Parry, J.W., Liu, Q., Han, X.H., Sun, C.H., Chen, B.Q., Yang, B.F., Effects of beta-ionone on mammary carcinogenesis and antioxidant status in rats treated with DMBA. Nutr. Cancer 62 (2010), 58–65.
46. [46] Scolastici, C., de Conti, A., Cardozo, M.T., Ong, T.P., Purgatto, E., Horst, M.A., Heidor, R., Furtado, K.S., Bassoli, B.K., Moreno, F.S., β-ionone inhibits persistent preneoplastic lesions during the early promotion phase of rat hepatocarcinogenesis: TGF-α, NF-κB, and p53 as cellular targets. Nutr. Cancer 66 (2014), 234–241.
47. [47] Asokkumar, S., Naveenkumar, C., Raghunandhakumar, S., Kamaraj, S., Anandakumar, P., Jagan, S., Devaki, T., Antiproliferative and antioxidant potential of beta-ionone against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Mol. Cell Biochem. 363 (2012), 335–345.
48. [48] de Moura Espíndola, R., Mazzantini, R.P., Ong, T.P., de Conti, A., Heidor, R., Moreno, F.S., Geranylgeraniol and β-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kB activation. Carcinogenesis 26 (2005), 1091–1099.
49. [49] Parameswaran, P.S., Naik, C.G., Das, B., Kamat, S.Y., Bose, A.K., Nair, M.S.R., Constituents of the brown alga Padina tetrastromatica (Hauck)-II. Indian J. Chem. 35B (1996), 463–467.
50. [50] D'Abrosca, B., DellaGreca, M., Fiorentino, A., Monaco, P., Oriano, P., Temussi, F., Structure elucidation and phytotoxicity of C13 nor-isoprenoids from Cestrum parqui. Phytochemistry 65 (2004), 497–505.
51. [51] Macías, F.A., Torres, A., Galindo, J.L., Varela, R.M., Alvarez, J.A., Molinillo, J.M., Bioactive terpenoids from sunflower leaves cv. Peredovick®. Phytochemistry 61 (2002), 687–692.
52. [52] Macías, F.A., Lacret, R., Varela, R.M., Nogueiras, C., Molinillo, J.M., Bioactive apocarotenoids from Tectona grandis. Phytochemistry 69 (2008), 2708–2715.
53. [53] Liu, X., Osawa, T., Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer. Biochem. Biophys. Res. Commun. 357 (2007), 187–193.
54. [54] Kensler, T.W., Mueller, G.C., Retinoic acid inhibition of the comitogenic action of mezerein and phorbol esters in bovine lymphocytes. Cancer Res. 38 (1978), 771–775.
55. [55] Kolb, T.M., Davis, M.A., The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) provokes a prolonged morphologic response and ERK activation in Tsc2-null renal tumor cells. Toxicol. Sci. 81 (2004), 233–242.
56. [56] Sharma, V., Chaudhary, A., Arora, S., Saxena, A.K., Ishar, M.P., β-ionone derived chalcones as potent antiproliferative agents. Eur. J. Med. Chem. 69 (2013), 310–315.
57. [57] Shishodia, S., Chaturvedi, M.M., Aggarwal, B.B., Role of curcumin in cancer therapy. Curr. Probl. Cancer 31 (2007), 243–305.
58. [58] Aggarwal, B.B., Surh, Y.J., Shishodia, S., Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. 2007, Springer-Verlag, US.
59. [59] Mirzaei, H., Emami, S., Recent advances of cytotoxic chalconoids targeting tubulin polymerization: synthesis and biological activity. Eur. J. Med. Chem. 121 (2016), 610–639.
60. [60] Ravindran, J., Prasad, S., Aggarwal, B.B., Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?. AAPS J. 11 (2009), 495–510.
61. [61] Das, M., Manna, K., Chalcone scaffold in anticancer armamentarium: a molecular insight. J. Toxicol., 2016, 2016, 10.1155/2016/7651047 Article ID 7651047.
62. [62] Fawzy, I.M., Youssef, K.M., Ismail, N.S.M., Gullbo, J., Abouzid, K.A.M., Design, synthesis and biological evaluation of novel curcumin analogs with anticipated anticancer activity. Future J. Pharm. Sci. 1 (2015), 22–31.
63. [63] Molaverdi, F., Khoobi, M., Emami, S., Alipour, M., Firuzi, O., Foroumadi, A., Dehghan, G., Miri, R., Shaki, F., Jafarpour, F., Shafiee, A., Polyoxygenated cinnamoylcoumarins as conformationally constrained analogs of cytotoxic diarylpentanoids: synthesis and biological activity. Eur. J. Med. Chem. 68 (2013), 103–110.
64. [64] Zhou, J., Geng, G., Batist, G., Wu, J.H., Synthesis and potential anti-prostate cancer activities of ionone-based chalcones. Bioorg. Med. Chem. Lett. 19 (2009), 1183–1186.
65. [65] Zhou, J., Geng, G., Wu, J.H., Synthesis and in vitro characterization of ionone-based chalcones as novel antiandrogens effective against multiple clinically relevant androgen receptor mutants. Investig. New Drugs 28 (2010), 291–298.
66. [66] Karin, M., Yamamoto, Y., Wang, Q.M., The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 (2004), 17–26.
67. [67] Setlur, S.R., Royce, T.E., Sboner, A., Mosquera, J.M., Demichelis, F., Hofer, M.D., Mertz, K.D., Gerstein, M., Rubin, M.A., Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. Cancer Res. 67 (2007), 10296–10303.
68. [68] Garg, R., Blando, J., Perez, C.J., Wang, H., Benavides, F.J., Kazanietz, M.G., Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase Cε (PKCε). J. Biol. Chem. 287 (2012), 37570–37582.
69. [69] Chen, C.D., Sawyers, C.L., NF-κB Activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol. Cell Biol. 22 (2002), 2862–2870.
70. [70] Gasparian, A.V., Yao, Y.J., Kowalczyk, D., Lyakh, L.A., Karseladze, A., Slaga, T.J., Budunova, I.V., The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J. Cell Sci. 115 (2002), 141–151.
71. [71] Liu, W., Zhou, J., Geng, G., Lin, R., Wu, J.H., Synthesis and in vitro characterization of ionone-based compounds as dual inhibitors of the androgen receptor and NF-κB. Investig. New Drugs 32 (2014), 227–234.
72. [72] Wan, M., Xu, L., Hua, L., Li, A., Li, S., Lu, W., Pang, Y., Cao, C., Liu, X., Jiao, P., Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents. Bioorg. Chem. 54 (2014), 38–43.
73. [73] Yong, J.P., Lu, C.Z., Wu, X., Potential anticancer agents. I. Synthesis of isoxazole moiety containing quinazoline derivatives and preliminarily in vitro anticancer activity. Anticancer Agents Med. Chem. 15 (2015), 131–136.
74. [74] Yong, J., Lu, C., Wu, X., Synthesis of isoxazole moiety containing thieno[2,3-d]pyrimidine derivatives and preliminarily in vitro anticancer activity (part II). Anticancer Agents Med. Chem. 15 (2015), 1148–1155.
75. [75] Kaur, K., Kumar, V., Sharma, A.K., Gupta, G.K., Isoxazoline containing natural products as anticancer agents: a review. Eur. J. Med. Chem. 77 (2014), 121–133.
76. [76] Baraldi, P.G., Guarneri, M., Manfredini, S., Simoni, D., Aghazade Tabrizi, M., Barbieri, R., Gambari, R., Nastruzzi, C., Synthesis of some isoxazole analogues of retinoids: biological effects toward tumor cell lines. Eur. J. Med. Chem. 25 (1990), 279–284.
77. [77] Galletti, P., Quintavalla, A., Ventrici, C., Giannini, G., Cabri, W., Penco, S., Gallo, G., Vincenti, S., Giacomini, D., Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors. ChemMedChem 4 (2009), 1991–2001.
78. [78] Oha, S., Jung, J.C., Avery, M.A., Synthesis of new β-lactam analogs and evaluation of their histone deacetylase (HDAC) activity. Z. Naturforschung 62b (2007), 1459–1464.
79. [79] Vannini, A., Volpari, C., Filocamo, G., Casavola, E.C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., Steinkühler, C., Di Marco, S.A., Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15064–15069.
80. [80] Balasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., Buggy, J.J., A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas. Leukemia 22 (2008), 1026–1034.
81. [81] Oehme, I., Deubzer, H.E., Wegener, D., Pickert, D., Linke, J.P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S.M., von Deimling, A., Fischer, M., Witt, O., Histone deacetylase 8 in neuroblastoma tumorigenesis. Clin. Cancer Res. 15 (2009), 91–99.
82. [82] Hossain, M.I., Świtalska, M., Peng, W., Takashima, M., Wang, N., Kaiser, M., Wietrzyk, J., Dan, S., Yamori, T., Inokuchi, T., Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures. Eur. J. Med. Chem. 69 (2013), 294–309.
83. [83] Jung, M., Synthesis and cytotoxicity of novel artemisinin analogs. Bioorg. Med. Chem. Lett. 7 (1997), 1091–1094.
84. [84] Wu, J.M., Shan, F., Wu, G.S., Li, Y., Ding, J., Xiao, D., Han, J.X., Atassi, G., Leonce, S., Caignard, D.H., Renard, P., Synthesis and cytotoxicity of artemisinin derivatives containing cyanoarylmethyl group. Eur. J. Med. Chem. 36 (2001), 469–479.
85. [85] Kwok, J.C., Richardson, D.R., The iron metabolism of neoplastic cells: alterations that facilitate proliferation?. Crit. Rev. Oncol. Hematol. 42 (2002), 65–78.
86. [86] Singh, R., Ishar, M.P.S., UV irradiation of arylidene-β-ionones in the presence of dioxygen: regioselective formation of stable endoperoxides. Tetrahedron Lett. 44 (2003), 1943–1945.
87. [87] Sharma, V., Gupta, V., Anthal, S., Saxena, A.K., Ishar, M.P.S., Photochemical formation and decomposition of 8-[β-arylethenyl]-2,2,6-trimethyl-7,9,10-trioxa-tricyclo[6.2.2.01,6]dodec-11-ene to novel 6-hydroxy-1,7,7-trimethyl-2-oxa-bicyclo[4.4.0]dec-4-en-3-one in the presence of oxygen. Tetrahedron Lett. 53 (2012), 5649–5651.
88. [88] Sharma, V., Chaudhry, A., Chashoo, G., Arora, R., Arora, S., Saxena, A.K., Ishar, M.P., β-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents. Eur. J. Med. Chem. 87 (2014), 228–236.
89. [89] Ishar, M.P., Singh, R., Kumar, K., Singh, G., Velmurugan, D., Pandi, A.S., Raj, S.S., Fun, H.K., Photochemistry of arylidene-beta-ionones: a highly efficient route to novel tricyclic ketones through intramolecular, exoselective photochemical (4 + 2) cycloadditions, occurring only in an aqueous-organic solvent. J. Org. Chem. 67 (2002), 2234–2240.
90. [90] Singh, R., Ishar, M.P.S., Girdhar, N.K., Velmurugan, D., Pandi, A.S., An unusual uncatalyzed Baeyer−Villiger oxidation of cyclobutanones to γ-lactones by air and its mechanistic implications. Eur. J. Org. Chem. 2002 (2002), 3734–3739.
91. [91] Ishar, M.P.S., Raj, T., Agrawal, S.K., Saxena, A.K., Singh, L., Singh, R., Bhella, S.S., Synthesis and cytotoxic activity of some novel polycyclic γ-butyrolactones. Bioorg. Med. Chem. Lett. 18 (2008), 4809–4812.
92. [92] Sharma, V., Chaudhary, A., Chashoo, G., Arora, S., Saxena, A.K., Ishar, M.P.S., Induction of apoptosis by cyclobutanones and derived polycyclic γ-lactones: a preliminary analysis of antiproliferative activity. Med. Chem. Commun. 6 (2015), 1626–1634.
93. [93] Aryapour, H., Riazi, G.H., Ahmadian, S., Foroumadi, A., Mahdavi, M., Emami, S., Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones. Pharm. Biol. 50 (2012), 1551–1560.
94. [94] Firoozpour, L., Edraki, N., Nakhjiri, M., Emami, S., Safavi, M., Kabudanian Ardestani, S., Khoshneviszadeh, M., Shafiee, A., Foroumadi, A., Cytotoxic activity evaluation and QSAR study of chromene-based chalcones. Arch. Pharm. Res. 35 (2012), 2117–2125.
95. [95] Azizmohammadi, M., Khoobi, M., Ramazani, A., Emami, S., Zarrin, A., Firuzi, O., Miri, R., Shafiee, A., 2H-Chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents. Eur. J. Med. Chem. 59 (2013), 15–22.
96. [96] Rahmani-Nezhad, S., Safavi, M., Pordeli, M., Kabudanian Ardestani, S., Khosravani, L., Pourshojaei, Y., Mahdavi, M., Emami, S., Foroumadi, A., Shafiee, A., Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents. Eur. J. Med. Chem. 86 (2014), 562–569.
97. [97] Emami, S., Dadashpour, S., Current developments of coumarin-based anti-cancer agents in medicinal chemistry. Eur. J. Med. Chem. 102 (2015), 611–630.
98. [98] Khoobi, M., Foroumadi, A., Emami, S., Safavi, M., Dehghan, G., Alizadeh, B.H., Ramazani, A., Ardestani, S.K., Shafiee, A., Coumarin-based bioactive compounds: facile synthesis and biological evaluation of coumarin-fused 1,4-thiazepines. Chem. Biol. Drug Des. 78 (2011), 580–586.
99. [99] Mahdavi, M., Pedrood, K., Safavi, M., Saeedi, M., Kabudanian Ardestani, S., Emami, S., Adib, M., Foroumadi, A., Shafiee, A., Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold. Eur. J. Med. Chem. 95 (2015), 492–499.
100. [100] Mahmoodi, M., Aliabadi, A., Emami, S., Safavi, M., Rajabalian, S., Mohagheghi, M.A., Khoshzaban, A., Samzadeh-Kermani, A., Lamei, N., Shafiee, A., Foroumadi, A., Synthesis and in vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes. Arch. Pharm. Chem. Life Sci. 343 (2010), 411–416.
101. [101] Aliabadi, A., Shamsa, F., Ostad, S.N., Emami, S., Shafiee, A., Davoodi, J., Foroumadi, A., Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents. Eur. J. Med. Chem. 45 (2010), 5384–5389.
102. [102] Ramazani, A., Khoobi, M., Torkaman, A., Zeinali Nasrabadi, F., Forootanfar, H., Shakibaie, M., Jafari, M., Ameri, A., Emami, S., Faramarzi, M.A., Foroumadi, A., Shafiee, A., One-pot, four-component synthesis of novel cytotoxic agents 1-(5-aryl-1,3,4-oxadiazol-2-yl)-1-(1H-pyrrol-2-yl)methanamines. Eur. J. Med. Chem. 78 (2014), 151–156.